TP53 and breast carcinoma: Previously, luminal subtype-specific p53 pathway dysregulation was identified in breast cancer brain metastases from analysis of RNA sequencing data of patient-matched primary breast tumours and resected brain metastatic tumour samples (N = 90) from a 45 patient cohort.